Life Sciences Stock News Bite - Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL) Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis : vimarsana.com

Life Sciences Stock News Bite - Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL) Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis

Life Sciences Stock News Bite - Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL) Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis

Related Keywords

United States , Andrew Hamer , Company Phase , Life Sciences Stock News Cardiol Therapeutics Inc , Youtube , Nasdaq , Twitter , Head Of Research Development , Drug Administration , Facebook , Life Sciences Stock News , United States Food , Orphan Drug Designation , Pilot Phase , Cardiol Therapeutic Chief Medical Officer , Fast Track , Breakthrough Therapy , Priority Review , Exploring Mining , Crypto Corner , Cannabis News , Biotech , Ife Sciences , Ardiol Therapeutics , Asdaq , Rdl , Sx , Rphan Drug , Reatment Of Pericarditis ,